Abaloparatide
Abaloparatide is a synthetic peptide analog of human parathyroid hormone-related protein (PTHrP). In 2017, the FDA approved its use in postmenopausal women with osteoporosis at high risk for fracture. Abaloparatide demonstrated a beneficial effect on BMD compared to teriparatide for postmenopausal w...
Saved in:
Main Authors: | Irtiqa Ayani Rathore (Author), Sana Bashir (Author), Vishal R Tandon (Author), Sudhaa Sharma (Author), Annil Mahajan (Author) |
---|---|
Format: | Book |
Published: |
Dr. Annil Mahajan,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidemiological Profile of Vitamin D Deficency Among Hypertensive Patients
by: Suman Kotwal, et al.
Published: (2024) -
Drug Holiday in Osteoporosis
by: Annil Mahajan, et al.
Published: (2024) -
Drug Holiday in Osteoporosis
by: Annil Mahajan, et al.
Published: (2024) -
Skin & Menopause
by: Sudhaa Sharma, et al.
Published: (2023) -
Bisphosphonate drug holidays: Can we recommend currently?
by: Vishal R Tandon, et al.
Published: (2014)